“Compared to weekly control, by improving targeting, daily control in prostate cancer IGRT significantly decreases the risks of recurrence and rectal toxicity but is associated with an increased risk ...

In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how the disease transforms into its most lethal form and identified a promising ...

Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...

For people battling prostate cancer, the fight can feel like a contest between the disease and the doctors. Their body is the battlefield, but they may nonetheless feel marginalized—more bystander ...